Marshall Wace LLP Acquires 4,284 Shares of Teleflex Incorporated (NYSE:TFX)

Marshall Wace LLP grew its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 8.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,087 shares of the medical technology company's stock after acquiring an additional 4,284 shares during the period. Marshall Wace LLP owned 0.12% of Teleflex worth $9,804,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Norges Bank bought a new stake in Teleflex in the fourth quarter worth $100,328,000. Invesco Ltd. lifted its position in shares of Teleflex by 48.1% in the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock worth $190,188,000 after buying an additional 347,003 shares during the last quarter. Diamond Hill Capital Management Inc. bought a new stake in shares of Teleflex during the 4th quarter worth about $46,696,000. Magnetar Financial LLC increased its holdings in shares of Teleflex by 105.2% during the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock valued at $74,990,000 after acquiring an additional 215,961 shares during the last quarter. Finally, Cooke & Bieler LP raised its stake in shares of Teleflex by 22.1% in the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after acquiring an additional 195,150 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Bank of America cut Teleflex from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Piper Sandler restated a "neutral" rating and issued a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Citizens Jmp lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Finally, Morgan Stanley decreased their price objective on Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Teleflex presently has an average rating of "Hold" and a consensus price target of $169.63.

Teleflex Price Performance

TFX traded down $0.58 during trading on Friday, hitting $135.08. The company's stock had a trading volume of 678,373 shares, compared to its average volume of 629,595. The firm's 50 day moving average price is $140.85 and its two-hundred day moving average price is $175.02. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $124.66 and a 12 month high of $249.91. The stock has a market capitalization of $6.26 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.01%. Teleflex's payout ratio is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.